The Incretin and Mitochondrial Pair combines Tirzepatide with MOTS-C for multi-pathway metabolic experiments in cell based models. One acts on incretin receptors, the other is mitochondrially derived, so the pair covers two separate arms of energy metabolism.
- Tirzepatide 10mg vial, a dual agonist at the GLP-1 and GIP receptors
- MOTS-C 10mg vial, a sixteen amino acid peptide encoded in mitochondrial DNA
Incretin and Mitochondrial Pair research applications
- cAMP assays in cell lines expressing GIPR or GLP-1R separately, the Tirzepatide readout
- Glucose uptake with 2-deoxyglucose or 2-NBDG in differentiated myotubes, alongside GLUT4 expression, the MOTS-C readout
- Paired cAMP and beta-arrestin concentration-response curves to quantify signalling bias at GLP-1R
Research profiles: Tirzepatide and MOTS-C
What is tested in this pair
This pair contains two products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Tirzepatide | 99.74% | Janoshik Analytical | 24 Sep 2026 | View |
| MOTS-C | 99.28% | Janoshik Analytical | 24 Sep 2026 | View |







